These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 25650700)
1. Signal attenuation as a rat model of obsessive compulsive disorder. Goltseker K; Yankelevitch-Yahav R; Albelda NS; Joel D J Vis Exp; 2015 Jan; (95):52287. PubMed ID: 25650700 [TBL] [Abstract][Full Text] [Related]
2. Selective alleviation of compulsive lever-pressing in rats by D1, but not D2, blockade: possible implications for the involvement of D1 receptors in obsessive-compulsive disorder. Joel D; Doljansky J Neuropsychopharmacology; 2003 Jan; 28(1):77-85. PubMed ID: 12496943 [TBL] [Abstract][Full Text] [Related]
3. 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam. Joel D; Ben-Amir E; Doljansky J; Flaisher S Behav Pharmacol; 2004 May; 15(3):241-52. PubMed ID: 15187582 [TBL] [Abstract][Full Text] [Related]
4. The effects of temporary inactivation of the orbital cortex in the signal attenuation rat model of obsessive compulsive disorder. Joel D; Klavir O Behav Neurosci; 2006 Aug; 120(4):976-83. PubMed ID: 16893303 [TBL] [Abstract][Full Text] [Related]
5. Excessive lever pressing following post-training signal attenuation in rats: a possible animal model of obsessive compulsive disorder? Joel D; Avisar A Behav Brain Res; 2001 Aug; 123(1):77-87. PubMed ID: 11377731 [TBL] [Abstract][Full Text] [Related]
6. The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder. Flaisher-Grinberg S; Klavir O; Joel D Int J Neuropsychopharmacol; 2008 Sep; 11(6):811-25. PubMed ID: 18339223 [TBL] [Abstract][Full Text] [Related]
7. The role of NMDA receptors in the signal attenuation rat model of obsessive-compulsive disorder. Albelda N; Bar-On N; Joel D Psychopharmacology (Berl); 2010 May; 210(1):13-24. PubMed ID: 20238210 [TBL] [Abstract][Full Text] [Related]
8. The role of the cholinergic system in the signal attenuation rat model of obsessive-compulsive disorder. Yankelevitch-Yahav R; Joel D Psychopharmacology (Berl); 2013 Nov; 230(1):37-48. PubMed ID: 23685859 [TBL] [Abstract][Full Text] [Related]
9. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology. Korff S; Harvey BH Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714 [TBL] [Abstract][Full Text] [Related]
10. 'Compulsive' lever pressing in rats is enhanced following lesions to the orbital cortex, but not to the basolateral nucleus of the amygdala or to the dorsal medial prefrontal cortex. Joel D; Doljansky J; Schiller D Eur J Neurosci; 2005 Apr; 21(8):2252-62. PubMed ID: 15869522 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity. Sesia T; Bizup B; Grace AA Int J Neuropsychopharmacol; 2013 Jul; 16(6):1295-307. PubMed ID: 23360787 [TBL] [Abstract][Full Text] [Related]
12. The role of the subthalamic nucleus in 'compulsive' behavior in rats. Winter C; Flash S; Klavir O; Klein J; Sohr R; Joel D Eur J Neurosci; 2008 Apr; 27(8):1902-11. PubMed ID: 18412611 [TBL] [Abstract][Full Text] [Related]
13. The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system. Schilman EA; Klavir O; Winter C; Sohr R; Joel D Neuropsychopharmacology; 2010 Mar; 35(4):1026-39. PubMed ID: 20072118 [TBL] [Abstract][Full Text] [Related]
14. High frequency stimulation and pharmacological inactivation of the subthalamic nucleus reduces 'compulsive' lever-pressing in rats. Klavir O; Flash S; Winter C; Joel D Exp Neurol; 2009 Jan; 215(1):101-9. PubMed ID: 18951894 [TBL] [Abstract][Full Text] [Related]
15. Strain differences in 'compulsive' lever-pressing. Brimberg L; Flaisher-Grinberg S; Schilman EA; Joel D Behav Brain Res; 2007 Apr; 179(1):141-51. PubMed ID: 17320982 [TBL] [Abstract][Full Text] [Related]
16. Enhanced reward-facilitating effects of d-amphetamine in rats in the quinpirole model of obsessive-compulsive disorder. Schmidt TT; Rea E; Shababi-Klein J; Panagis G; Winter C Int J Neuropsychopharmacol; 2013 Jun; 16(5):1083-91. PubMed ID: 23043789 [TBL] [Abstract][Full Text] [Related]
17. High but not low frequency stimulation of both the globus pallidus and the entopeduncular nucleus reduces 'compulsive' lever-pressing in rats. Klavir O; Winter C; Joel D Behav Brain Res; 2011 Jan; 216(1):84-93. PubMed ID: 20654653 [TBL] [Abstract][Full Text] [Related]
18. Obsessive-compulsive spectrum disorders in obsessive-compulsive disorder and other anxiety disorders. Lochner C; Stein DJ Psychopathology; 2010; 43(6):389-96. PubMed ID: 20847586 [TBL] [Abstract][Full Text] [Related]
19. Evidence for Distinct Forms of Compulsivity in the SAPAP3 Mutant-Mouse Model for Obsessive-Compulsive Disorder. Ehmer I; Crown L; van Leeuwen W; Feenstra M; Willuhn I; Denys D eNeuro; 2020; 7(2):. PubMed ID: 32234806 [TBL] [Abstract][Full Text] [Related]
20. The signal attenuation rat model of obsessive-compulsive disorder: a review. Joel D Psychopharmacology (Berl); 2006 Jul; 186(4):487-503. PubMed ID: 16718482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]